Effective connectivity changes in LSD-induced altered states of consciousness in humans
Open accessAbstract
Psychedelics exert unique effects on human consciousness. The thalamic filter model suggests that core effects of psychedelics may result from gating deficits, based on a disintegration of information processing within cortico–striato–thalamo-cortical (CSTC) feedback loops. To test this hypothesis, we characterized changes in directed (effective) connectivity between selected CTSC regions after acute administration of lysergic acid diethylamide (LSD), and after pretreatment with Ketanserin (a selective serotonin 2A receptor antagonist) plus LSD in a double-blind, randomized, placebo-controlled, cross-over study in 25 healthy participants. We used spectral dynamic causal modeling (DCM) for resting-state fMRI data. Fully connected DCM models were specified for each treatment condition to investigate the connectivity between the following areas: thalamus, ventral striatum, posterior cingulate cortex, and temporal cortex. Our results confirm major predictions proposed in the CSTC model and provide evidence that LSD alters effective connectivity within CSTC pathways that have been implicated in the gating of sensory and sensorimotor information to the cortex. In particular, LSD increased effective connectivity from the thalamus to the posterior cingulate cortex in a way that depended on serotonin 2A receptor activation, and decreased effective connectivity from the ventral striatum to the thalamus independently of serotonin 2A receptor activation. Together, these results advance our mechanistic understanding of the action of psychedelics in health and disease. This is important for the development of new pharmacological therapeutics and also increases our understanding of the mechanisms underlying the potential clinical efficacy of psychedelics.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
5-HT2A receptor agonizing psychedelics result in modulation of cortical and subcortical circuitry.
“In this formulation, 5-HT 2A R agonizing psychedelics result in modulation of cortical and subcortical circuitry (Preller et al., 2019;Vollenweider and Preller, 2020), altering the flow of information in the brain via changes in how PFC L5 pyramidal neurons expressing 5-HT 2A R regulate important thalamic nuclei (reticular nucleus, mediodorsal thalamus) (Inserra et al., 2021b).”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as Preller et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The role of the posterior cingulate cortex in cognition and disease
Leech, R., & Sharp, D. J. (2014) · Brain · doi:10.1093/brain/awt162 · Cited by 2,247 · see citing works
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · see citing works
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252 · see citing works
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211 · see citing works
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859 · see citing works
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · see citing works
Self-citationFinding the self by losing the self: neural correlates of ego-dissolution under psilocybin
Lebedev, A. V., Lövdén, M., Rosenthal, G., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2015) · Human Brain Mapping · doi:10.1002/hbm.22833 · Cited by 339 · see citing works
The paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293 · see citing works
Effect of Psilocybin on Empathy and Moral Decision-Making
Pokorny, T., Preller, K. H., Kometer, M., Dziobek, I., & Vollenweider, F. X. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx047 · Cited by 197 · see citing works
Self-citationEffects of serotonin 2A/1A receptor stimulation on social exclusion processing
Preller, K. H., Pokorny, T., Hock, A., Kraehenmann, R., Stämpfli, P., Seifritz, E., Scheidegger, M., & Vollenweider, F. X. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524187113 · Cited by 169 · see citing works
Self-citationAkeju, O., Loggia, M. L., Catana, C., Pavone, K. J., Vazquez, R., Rhee, J., Contreras Ramirez, V., Chonde, D. B., Izquierdo-Garcia, D., Arabasz, G., et al. (2014) · eLife · doi:10.7554/elife.04499 · Cited by 168 · see citing works
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155 · cited 1× · see citing works
“However, despite renewed scientific and clinical interest in these substances, there are still major gaps in our knowledge regarding the effects of psychedelics on the brain and their pharmacological mechanism of action (2).”
Background
Flagged first, then by citations
Research works printed but not linked: 52
- [1]Preller KH Vollenweider FX 2016 Phenomenology, structure, and dynamic of psychedelic states Curr Top Behav Neurosci 36 221 256, and erratum (2018) 36:1 28025814
- [3]Geyer MA Vollenweider FX 2008 Serotonin research: Contributions to understanding psychoses Trends Pharmacol Sci 29 445 453 19086254
- [4]Vollenweider FX Geyer MA 2001 A systems model of altered consciousness: Integrating natural and drug-induced psychoses Brain Res Bull 56 495 507 11750795
- [5]Schlösser R Gesierich T Kaufmann B Vucurevic G Stoeter P 2003 Altered effective connectivity in drug free schizophrenic patients Neuroreport 14 2233 2237 14625454
- [6]Anticevic A 2014 Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness Cereb Cortex 24 3116 3130 23825317 PMC4224238
- [7]Schmid Y 2015 Acute effects of lysergic acid diethylamide in healthy subjects Biol Psychiatry 78 544 553 25575620
- [8]Quednow BB Kometer M Geyer MA Vollenweider FX 2012 Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers Neuropsychopharmacology 37 630 640 21956447 PMC3260978
- [9]Vollenweider FX Csomor PA Knappe B Geyer MA Quednow BB 2007 The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval Neuropsychopharmacology 32 1876 1887 17299516
- [13]Muthukumaraswamy SD 2013 Broadband cortical desynchronization underlies the human psychedelic state J Neurosci 33 15171 15183 24048847 PMC6618409
- [14]Carhart-Harris RL 2012 Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proc Natl Acad Sci USA 109 2138 2143 22308440 PMC3277566
- [15]Friston KJ Kahan J Biswal B Razi A 2014 A DCM for resting state fMRI Neuroimage 94 396 407 24345387 PMC4073651
- [16]Friston KJ 2016 Bayesian model reduction and empirical Bayes for group (DCM) studies Neuroimage 128 413 431 26569570 PMC4767224
- [17]Preller KH 2017 The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation Curr Biol 27 451 457 28132813
- [18]Preller KH 2018 Role of the 5-HT2A receptor in self- and other-initiated social interaction in lysergic acid diethylamide-induced states: A pharmacological fMRI study J Neurosci 38 3603 3611 29555857 PMC6596041
- [21]Sherman SM 2017 Functioning of circuits connecting thalamus and cortex Compr Physiol 7 713 739 28333385
- [22]Tononi G Edelman GM 1998 Consciousness and complexity Science 282 1846 1851 9836628
- [23]Ward LM 2011 The thalamic dynamic core theory of conscious experience Conscious Cogn 20 464 486 21349742
- [24]Picchioni D 2014 Decreased connectivity between the thalamus and the neocortex during human nonrapid eye movement sleep Sleep (Basel) 37 387 397 PMC3900615 24497667
- [25]White NS Alkire MT 2003 Impaired thalamocortical connectivity in humans during general-anesthetic-induced unconsciousness Neuroimage 19 402 411 12814589
- [26]Liu X Lauer KK Ward BD Li SJ Hudetz AG 2013 Differential effects of deep sedation with propofol on the specific and nonspecific thalamocortical systems: A functional magnetic resonance imaging study Anesthesiology 118 59 69 23221862 PMC4080838
- [28]Huang Z 2014 Altered temporal variance and neural synchronization of spontaneous brain activity in anesthesia Hum Brain Mapp 35 5368 5378 24867379 PMC6869449
- [29]Bolkan SS 2017 Thalamic projections sustain prefrontal activity during working memory maintenance Nat Neurosci 20 987 996 28481349 PMC5501395
- [30]Anticevic A 2015 Association of thalamic dysconnectivity and conversion to psychosis in youth and young adults at elevated clinical risk JAMA Psychiatry 72 882 891 26267151 PMC4892891
- [31]Ramsay IS Nienow TM MacDonald AW 3rd 2017 Increases in intrinsic thalamocortical connectivity and overall cognition following cognitive remediation in chronic schizophrenia Biol Psychiatry Cogn Neurosci Neuroimaging 2 355 362 28584882 PMC5455781
- [32]Guller Y Tononi G Postle BR 2012 Conserved functional connectivity but impaired effective connectivity of thalamocortical circuitry in schizophrenia Brain Connect 2 311 319 23020103 PMC3621336
- [33]Woodward ND Heckers S 2016 Mapping thalamocortical functional connectivity in chronic and early stages of psychotic disorders Biol Psychiatry 79 1016 1025 26248537 PMC4698230
- [34]Anticevic A 2017 Understanding the role of thalamic circuits in schizophrenia neuropathology Schizophr Res 180 1 3 27939828
- [35]Chen Y 2016 Abnormal resting-state functional connectivity of the left caudate nucleus in obsessive-compulsive disorder Neurosci Lett 623 57 62 27143323
- [36]Kanai R Komura Y Shipp S Friston K 2015 Cerebral hierarchies: Predictive processing, precision and the pulvinar Philos Trans R Soc Lond B Biol Sci 370 20140169 25823866 PMC4387510
- [37]Müller F 2017 Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations Acta Psychiatr Scand 136 648 657 28940312 PMC5698745
- [38]Preller KH 2018 Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor eLife 7 e35082 30355445 PMC6202055
- [39]Sampedro F 2017 Assessing the psychedelic “after-glow” in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities Int J Neuropsychopharmacol 20 698 711 28525587 PMC5581489
- [40]Kometer M Schmidt A Jäncke L Vollenweider FX 2013 Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations J Neurosci 33 10544 10551 23785166 PMC6618596
- [41]Valle M 2016 Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans Eur Neuropsychopharmacol 26 1161 1175 27039035
- [42]Kometer M Pokorny T Seifritz E Volleinweider FX 2015 Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations Psychopharmacology (Berl) 232 3663 3676 26231498
- [43]Müller N 2013 You can’t stop the music: Reduced auditory alpha power and coupling between auditory and memory regions facilitate the illusory perception of music during noise Neuroimage 79 383 393 23664946
- [45]Sharaev MG Zavyalova VV Ushakov VL Kartashov SI Velichkovsky BM 2016 Effective connectivity within the default mode network: Dynamic causal modeling of resting-state fMRI data Front Hum Neurosci 10 14 26869900 PMC4740785
- [46]Zhou Y 2018 The hierarchical organization of the default, dorsal attention and salience networks in adolescents and young adults Cereb Cortex 28 726 737 29161362 PMC5929108
- [47]Razi A Kahan J Rees G Friston KJ 2015 Construct validation of a DCM for resting state fMRI Neuroimage 106 1 14 25463471 PMC4295921
- [48]Carter RM Huettel SA 2013 A nexus model of the temporal-parietal junction Trends Cogn Sci 17 328 336 23790322 PMC3750983
- [50]Kometer M 2012 Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors Biol Psychiatry 72 898 906 22578254
- [52]Mwansisya TE 2017 Task and resting-state fMRI studies in first-episode schizophrenia: A systematic review Schizophr Res 189 9 18 28268041
- [53]Brown EC Clark DL Hassel S MacQueen G Ramasubbu R 2017 Thalamocortical connectivity in major depressive disorder J Affect Disord 217 125 131 28407555
- [56]Marona-Lewicka D Thisted RA Nichols DE 2005 Distinct temporal phases in the behavioral pharmacology of LSD: Dopamine D2 receptor-mediated effects in the rat and implications for psychosis Psychopharmacology (Berl) 180 427 435 15723230
- [57]Marona-Lewicka D Nichols DE 2007 Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action Pharmacol Biochem Behav 87 453 461 17618679
- [58]Fischer R 1971 A cartography of the ecstatic and meditative states Science 174 897 904 5123809
- [60]Tagliazucchi E 2016 Increased global functional connectivity correlates with LSD-induced ego dissolution Curr Biol 26 1043 1050 27085214
- [61]Tagliazucchi E Carhart-Harris R Leech R Nutt D Chialvo DR 2014 Enhanced repertoire of brain dynamical states during the psychedelic experience Hum Brain Mapp 35 5442 5456 24989126 PMC6869695
- [62]Lewis CR 2017 Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow Neuroimage 159 70 78 28711736
- [63]Sheehan DV 1998 The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 22 33, quiz 34–57 9881538
- [66]Persson B Pettersson A Hedner T 1987 Pharmacokinetics of ketanserin in patients with essential hypertension Eur J Clin Pharmacol 32 259 265 3595699
- [67]Studerus E Gamma A Vollenweider FX 2010 Psychometric evaluation of the altered states of consciousness rating scale (OAV) PLoS One 5 e12412 20824211 PMC2930851
Cited by
Sorted by citations
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180 · see citing works
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570 · see citing works
Self-citationDoss, M. K., Považan, M., Rosenberg, M. D., Sepeda, N. D., Davis, A. K., Finan, P. H., Smith, G. S., Pekar, J. J., Barker, P. B., Griffiths, R. R., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01706-y · Cited by 356 · see citing works
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360 · see citing works
Cellular Mechanisms of Conscious Processing
Aru, J., Suzuki, M., & Larkum, M. E. (2020) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2020.07.006 · Cited by 321 · see citing works
Andersen, K. A. A., Carhart‐Harris, R., Nutt, D. J., & Erritzoe, D. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13249 · Cited by 347 · see citing works
Default Mode Network Modulation by Psychedelics: A Systematic Review
Gattuso, J. J., Perkins, D., Ruffell, S., Lawrence, A. J., Hoyer, D., Jacobson, L. H., Timmermann, C., Castle, D., Rossell, S. L., Downey, L. A., et al. (2023) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac074 · Cited by 256 · see citing works
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
van Elk, M., & Yaden, D. B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104793 · Cited by 221 · see citing works
Consciousness and complexity: a consilience of evidence
Sarasso, S., Casali, A. G., Casarotto, S., Rosanova, M., Sinigaglia, C., & Massimini, M. (2021) · Neuroscience of Consciousness · doi:10.1093/nc/niab023 · Cited by 171 · see citing works
Timmermann, C., Bauer, P. R., Gosseries, O., Vanhaudenhuyse, A., Vollenweider, F., Laureys, S., Singer, T., Antonova, E., & Lutz, A. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2022.11.006 · Cited by 150 · see citing works
Self-citationGreenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772054 · Cited by 94 · see citing works
Psychedelics, Sociality, and Human Evolution
Rodríguez Arce, J. M., & Winkelman, M. J. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.729425 · Cited by 86 · see citing works
Psychedelics and Neural Plasticity: Therapeutic Implications
Grieco, S. F., Castrén, E., Knudsen, G. M., Kwan, A. C., Olson, D. E., Zuo, Y., Holmes, T. C., & Xu, X. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1121-22.2022 · Cited by 82 · see citing works
“In this formulation, 5-HT 2A R agonizing psychedelics result in modulation of cortical and subcortical circuitry (Preller et al., 2019; Vollenweider and Preller, 2020), altering the flow of information in the brain via changes in how PFC L5 pyramidal neurons expressing 5-HT 2A R regulate important…”
Kotler, S., Mannino, M., Kelso, S., & Huskey, R. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104956 · Cited by 52 · see citing works
Onofrj, M., Russo, M., Delli Pizzi, S., De Gregorio, D., Inserra, A., Gobbi, G., & Sensi, S. L. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02691-0 · Cited by 43 · see citing works
Thomas, G. E. C., Zeidman, P., Sultana, T., Zarkali, A., Razi, A., & Weil, R. S. (2022) · Brain Communications · doi:10.1093/braincomms/fcac329 · Cited by 38 · see citing works
Self-citationPsychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action
Rieser, N. M., Herdener, M., & Preller, K. H. (2021) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2021_284 · Cited by 37 · see citing works
Self-citationFrymann, T., Whitney, S., Yaden, D. B., & Lipson, J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.863247 · Cited by 30 · see citing works
Do psychedelics facilitate emergence of unconscious psychological processes
Lindegaard, T. (2023) · Psychodynamic Psychiatry · doi:10.1521/pdps.2023.51.3.270 · Cited by 18 · see citing works
Uncovering psychedelics: from neural circuits to therapeutic applications
Melani, A., Bonaso, M., Biso, L., Zucchini, B., Conversano, C., & Scarselli, M. (2025) · Pharmaceuticals · doi:10.3390/ph18010130 · Cited by 17 · see citing works
- Authors
- Preller, K. H., Razi, A., Zeidman, P., Stämpfli, P., Friston, K. J., & Vollenweider, F. X.
- Affiliations
- Wellcome Centre for Human Neuroimaging (GB)
- NED University of Engineering and Technology (PK)
- University of Zurich (CH)
- University Hospital Zurich (CH)
- Corresponding author
- Preller, Katrin H.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2019-01-28
- Volume
- 116
- Issue
- 7
- Pages
- 2743-2748
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6377471
- OpenAlex
- W2911514809
- Cited by
- 292
- References
- 12
- Citations by year
- 2026: 25 · 2025: 31 · 2024: 46 · 2023: 66 · 2022: 44 · 2021: 40 · 2020: 28 · 2019: 11
- FWCI
- 35.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Greater South Information System
- Funders
- Swiss National Science Foundation (1270 P2ZHP1_161626)
- Swiss Neuromatrix Foundation (2015-0103)
- Usona Institute (2015-2056)
- Australian Research Council DECRA Fellowship (DE170100128)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Keywords
- lysergic acid diethylamide, LSD, psychedelics, altered states of consciousness, effective connectivity, thalamic gating, 5-HT2A receptor, ketanserin, posterior cingulate cortex, ventral striatum, thalamus, temporal cortex, dynamic causal modeling, resting-state fMRI
- MeSH terms
- Brain, Consciousness, Double-Blind Method, Hallucinogens, Humans, Lysergic Acid Diethylamide, Placebos, Serotonin Antagonists, Cross-Over Studies, Receptor, Serotonin, 5-HT2A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review